Tokyo, Japan, February 6, 2023 - Teijin Limited has made the following personnel changes effective as of April 1, 2023.
New Position | Current Position | Name |
Mission Executive, Member of the Board | Senior Executive Officer, Representative Director of the Board | Akihisa |
Assistant to President | Chief Financial Officer | Nabeshima |
Mission Executive, Member of the Board | Executive Officer, Member of the Board | Toshiya |
Assistant to Chief Sustainability Officer (for Safety Promotion | Chief Social Responsibility Officer | Koyama |
Project) | Responsible for Corporate Audit Department | |
Senior Executive Officer, Representative Director of the Board | Executive Officer, Member of the Board | Eiji |
Chief Financial Officer | President, Material Business of Teijin Group | Ogawa |
Responsible for Procurement and Logistics Division | ||
Senior Executive Officer, Member of the Board | Executive Officer, Member of the Board | Naohiko |
Chief Officer (Corporate Strategy) | Chief Officer (Corporate Strategy) | Moriyama |
Mission Executive | Teijin Group Executive Officer | Ichiro |
Deputy President, Teijin Pharma Limited | President, Healthcare Business of Teijin Group | Watanabe |
President, Teijin Pharma Limited | ||
Teijin Group Corporate Officer | Teijin Group Corporate Officer | Yasuhiko |
General Manager, Research, Development & Technology Unit, | Management Coordinator for the President, Healthcare | Kuriyama |
Teijin Pharma Limited | Business of Teijin Group (for Strategy Promotion) | |
Mission Executive | Teijin Group Corporate Officer | Karola |
Teijin Group Chief Representative in Europe | Chief Human Resources Officer | Japke |
President, Teijin Holdings Europe B.V. | ||
Deputy Chief Human Resources Officer (for Overseas HR and | ||
D&I promotion) | ||
Teijin Group Corporate Officer | Teijin Group Corporate Officer | Tsutomu |
Chief Officer (Global Administration) | Chief Officer (Global Business Strategy) | Igawa |
Mission Executive | Teijin Group Corporate Officer | Kenichiro |
Deputy President, Teijin Pharma Limited | Deputy President, Teijin Pharma Limited | Kataoka |
Mission Executive | Teijin Group Corporate Officer | Tadashi |
General Manager, Battery Materials & Membrane Division | General Manager, Material New Business Division | Sakata |
Teijin Group Executive Officer | Teijin Group Corporate Officer | Noboru |
Chief Sustainability Officer | General Manager, Resin & Plastic Processing Business Unit | Yamanishi |
Responsible for Engineering Division | ||
Responsible for Corporate Audit Department | ||
Mission Executive | Teijin Group Corporate Officer | Toshihiko |
Senior Corporate External Affairs Officer | Senior Corporate Project Officer | Sakaguchi |
Responsible for External Affairs Group | ||
New Position | Current Position | Name |
Teijin Group Corporate Officer | Teijin Group Corporate Officer | Noriko |
General Manager, New Business Development Unit | General Manager, Corporate Business Incubation Division | Higuchi |
Responsible for Intellectual Property Department | ||
Mission Executive | Teijin Group Corporate Officer | Ton de |
General Manager, Environmental Solution Division | General Manager, Material Technology Center | Weijer |
Mission Executive, Advisor for Technology | Teijin Group Corporate Officer | Akihiko |
General Manager, Intellectual Property Department | Chief Officer (Legal, Intellectual Property) | Uchiyama |
General Manager, Intellectual Property Department | ||
Mission Executive | Teijin Group Corporate Officer | Teruo |
General Manager, Engineering Division | Chief Officer (Engineering) | Aoyagi |
Deputy Chief Sustainability Officer (for Disaster Prevention) | Deputy Chief Social Responsibility Officer (for Disaster | |
Prevention) | ||
Director, Effective Utilization of Factories Project | ||
Director, Iwakuni Factory and Matsuyama Factory | ||
Teijin Group Corporate Officer | Teijin Group Corporate Officer | Junji |
General Manager, Resin & Plastic Processing Business Unit | Deputy Chief Financial Officer | Kitahama |
General Manager, Accounting Department | ||
Mission Executive | Teijin Group Corporate Officer | Toshitake |
Deputy Chief Human Resources Officer (for Special Project) | Deputy Chief Human Resources Officer, Regional Human | Karasawa |
Resources Director (Japan) | ||
General Manager, Operational Reforms Promotion Team | ||
Mission Executive | Teijin Group Corporate Officer | Shuichi |
General Manager, CSR Planning and Promotion Department | Deputy Chief Social Responsibility Officer (for promoting SDGs) | Osaki |
General Manager, CSR Planning and Promotion Department | ||
Teijin Group Executive Officer | Teijin Group Corporate Officer | Masaki |
General Manager, Healthcare Business Unit | Executive Director, General Manager, Research, Development | Taneda |
President, Teijin Pharma Limited | & Technology Unit, Teijin Pharma Limited | |
Mission Executive | Teijin Group Corporate Officer | Tomoko |
Deputy Chief Officer (Corporate Strategy) (for Investor and | Deputy Chief Officer (Corporate Strategy) (for stakeholder | Torii |
Public Relations, Branding) | communication) | |
General Manager, Corporate Branding Department | General Manager, Corporate Branding Department | |
Manager, Stakeholder Communication Coordination Group | Manager, Stakeholder Communication Coordination Group | |
Mission Executive | Teijin Group Corporate Officer | Toru |
Deputy Chief Financial Officer | General Manager, Material Business Strategic Planning and | Yamaura |
Control Division | ||
Mission Executive | Teijin Group Corporate Officer | Takayuki |
General Manager, Regenerative Medicine & Implantable | Deputy General Manager, Corporate Business Incubation | Nakano |
Medical Device Division | Division | |
General Manager, Regenerative Medicine New Business | General Manager, Regenerative Medicine New Business | |
Department | Department |
New Position | Current Position | Name |
Teijin Group Executive Officer | President and Chief Executive Officer, TEIJIN FRONTIER | Yasunari |
General Manager, Fibers & Products Converting Business Unit | CO., LTD. | Hirata |
President and Chief Executive Officer, TEIJIN FRONTIER CO., LTD. | ||
Teijin Group Corporate Officer | - | Fumiaki |
Chief Human Resources Officer | Sakurai | |
Mission Executive | Advisor for Technology | Hiroyuki |
Assistant to General Manager, New Business Development Unit | Umetani | |
Deputy General Manager, Research, Development & | Teijin Group Chief Representative in Europe | Tomohide |
Technology Unit, Teijin Pharma Limited | President, Teijin Holdings Europe B.V. | Ida |
General Manager, Accounting Department | Deputy General Manager, Material Business Strategic | Tetsu |
Planning and Control Division (for Special Project) | Yura | |
Manager, Strategic Business Planning Section, Composites | ||
Business Corporate Planning and Administrative Department | ||
Senior Advisor, Member of the Board | Chairperson of Teijin Limited, Member of the Board | Jun |
Suzuki | ||
Honorary Advisor | Senior Advisor | Shigeko |
Oyagi | ||
Scheduled to retire (Dated March 31, 2023) | Teijin Group Corporate Officer | Tsutomu |
Chief Information Officer | Morioka | |
Scheduled to retire (Dated March 31, 2023) | Teijin Group Corporate Officer | Yutaka |
Management Coordinator for the President, Material Business | Horie | |
of Teijin Group (for Intelligence) | ||
Scheduled to retire (Dated March 31, 2023) | Honorary Advisor | Toru |
Nagashima |
- The appointments for the directors of Group Companies shall be effective upon the approval of general meetings of shareholders and the board of directors meetings of each Company.
About the Teijin Group
Teijin (TSE: 3401) is a technology-driven global group offering advanced solutions in the fields of environmental value; safety, security and disaster mitigation; and demographic change and increased health consciousness. Originally established as Japan's first rayon manufacturer in 1918, Teijin has evolved into a unique enterprise encompassing three core business domains: high-performance materials including aramid, carbon fibers and composites, and also resin and plastic processing, films, polyester fibers and products converting; healthcare including pharmaceuticals and home healthcare equipment for bone/joint, respiratory and cardiovascular/metabolic diseases, nursing care and pre-symptomatic healthcare; and IT including B2B solutions for medical, corporate and public systems as well as packaged software and B2C online services for digital entertainment. Deeply committed to its stakeholders, as expressed in the brand statement "Human Chemistry, Human Solutions," Teijin aims to be a company that supports the society of the future. The group comprises some 170 companies and employs some 20,000 people across 20
countries worldwide. Teijin posted consolidated sales of JPY 926.1 billion (USD 7.2 billion) and total assets of JPY 1,207.6 billion (USD 9.4 billion) in the fiscal year that ended on March 31, 2022.
Please visitwww.teijin.com
Press Contact
Investor and Public Relations Department Teijin Limited
+81 (0)3 3506 4055 pr@teijin.co.jp
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Teijin Limited published this content on 06 February 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 February 2023 02:39:00 UTC.